Teva Pharmaceutical Industries' Yitzhak Peterburg says business is running as usual as it is still too early to determine Brexit's impact.
CNBC's Meg Tirrell talks with Merck's Roger Perlmutter about advances the drugmaker has made in treating cancer, including immunotherapy drug KEYTRUDA. Perlmutter also addresses concerns over the high price of drugs.
A drug resistant bacteria is putting health officials on high alert, in which some are looking at the need for new antibiotics. Ezekiel Emanuel, Center for American Progress, discusses the dangers of over-prescription, and urges creation of new antibiotics.
Health officials report the first case of a patient with an infection resistant to all known antibiotics.
Capsule says its home-delivery prescription service will be faster and simpler for many consumers.
Researchers claim acetaminophen, the active ingredient in the medicine can decrease empathy.
More than half of respondents say they would support removing prescription drug advertisements from TV.
Best ways to reduce your prescription drug expenses – from using online retailers to getting 90-day supply.
CNBC's Meg Tirrell reports on data from clinical trials by Alder and its migraine drug ALD403.
GW Pharmaceuticals CEO Justin Gover, discusses the potential for Epidiolex for the treatment of Dravet syndrome.
The House Oversight Committee wants Turing Pharmaceuticals founder Martin Shkreli to testify on the issue of raising drug prices, reports CNBC's Eamon Javers.
CNBC's Meg Tirrell reports on the ups and downs for Chimerix's experimental drug brincidofovir.
CEO and MD Christina Holgate tells CNBC why the Supplement brand Blackmores decided to open its first retail store.
Health groups called for Turing Pharmaceuticals to follow through on its promise to lower the price of a recently acquired drug.
CNBC's Meg Tirrell reports a number of health groups have appealed to Turing Pharmaceuticals asking the company to lower its drug price of Daraprim.
Spark Therapeutics is working on an experimental gene therapy for an inherited eye disorder, and it has the potential to be the first gene therapy on the market in the U.S.
Spark Therapeutics' gene therapy for rare, inherited forms of blindness met the goals of a late-stage study.
AbbVie said its experimental drug improved symptoms of rheumatoid arthritis in patients in two mid-stage studies.
CNBC's Meg Tirrell speaks to Alnylam Pharmaceuticals CEO John Maraganore, about drug pricing in the U.S.
Democratic presidential candidate Hillary Clinton unveils her plan to lower prescription drug costs.